March 7, 2018 Life Science Tools

Pacific Biosciences Enhances Performance and Affordability of Key Applications on the Sequel System

MENLO PARK, Calif., March 07, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced a new version of Sequel® Software (V5.1) and a new polymerase. Combined, these enhancements increase throughput and the overall performance of Single Molecule, Real-Time (SMRT®) Sequencing for key applications such as de... Read more

February 12, 2018 Life Science Tools PR/Corporate

Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock

MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.  Pacific Biosciences also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number... Read more

February 12, 2018 Life Science Tools Liq. Handling & Robotics PR/Corporate Product Launch

SMRT Sequencing of Human Genomes to be Showcased at AGBT Conference

MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California Inc., (Nasdaq:PACB) today announced its Single Molecule, Real-Time (SMRT®) Sequencing technology will be demonstrated in several presentations and posters at the annual Advances in Genome Biology & Technology (AGBT) conference taking place February 12-15 in Orlando. PacBio is also an official sponsor of this... Read more

February 8, 2018 Licensing, IP, and Legal Life Science Tools

Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore

MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) announced today that the U.S. International Trade Commission (the “ITC”) has terminated its investigation into whether Oxford Nanopore’s MinION and PromethION devices and associated consumables, reagents, and software infringe one or more claims of U.S. Patent Nos. 9,404,146 and 9,542,527, owned... Read more

February 8, 2018 Licensing, IP, and Legal

Oxford Nanopore Successfully Defends PacBio lawsuit

Thu 8th February 2018 In November 2016, PacBio filed a Complaint with the International Trade Commission (“ITC”) alleging that Oxford Nanopore infringed two of PacBio’s patents and seeking to prevent Oxford Nanopore from selling its product in the United States. Today, the ITC Commission has made a Final Determination affirming the Administrative Judge’s decision that... Read more

January 25, 2018 Environ, Ag./Food & Bev Life Science Tools M&A, Partnerships Microscopy

BGI Increases Long-Read Sequencing Capacity with Purchase of 10 PacBio Sequel Systems

MENLO PARK, California and SHENZHEN, China, Jan. 25, 2018 (GLOBE NEWSWIRE) — BGI, one of the world’s largest genomics organizations, and Pacific Biosciences of California, Inc. (Nasdaq: PACB), the leader in long-read sequencing, today announced an agreement by BGI Genomics to purchase an additional 10 Sequel® Systems. This will significantly expand the capacity for Single Molecule, Real-Time... Read more

November 2, 2017 Life Science Tools PR/Corporate

Pacific Biosciences Appoints Kathy Ordoñez as Chief Commercial Officer

MENLO PARK, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) announced today that Kathy Ordoñez has been named Chief Commercial Officer and Executive Vice President. Ms. Ordoñez brings more than thirty years of experience in the life sciences and diagnostics industries, with senior roles at Hoffmann-La Roche, Celera, Quest Diagnostics and... Read more

October 16, 2017 Life Science Tools

Recent Projects Highlight Success of SMRT Sequencing for Characterizing Structural Variation in Human Genomes

MENLO PARK, Calif., Oct. 16, 2017 (GLOBE NEWSWIRE) — A series of publications and initiatives from the genomics community demonstrates the rapid adoption of Single Molecule, Real-Time (SMRT®) Sequencing for discovering structural variants throughout the human genome. As these previously overlooked structural variants have been elucidated, there is increasing recognition among scientists of the important... Read more

October 9, 2017 Informatics & Software Life Science Tools M&A, Partnerships

PacBio and Bluebee Launch De Novo Genome Assembly Pipeline on the Bluebee Analysis Platform

RIJSWIJK, The Netherlands and MENLO PARK, Calif., — October 9th, 2017 — Bluebee, a company driving genomic data-driven medicine, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, announced they have integrated the PacBio® de novo assembly pipeline onto the Bluebee® genomics analysis platform. The integration creates a simplified workflow and fully... Read more

October 3, 2017 Life Science Tools PR/Corporate

Structural Variation Detection a Key Focus of PacBio Sequencing Projects Presented at ASHG Annual Meeting

MENLO PARK, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that the human genetics community is demonstrating increasing recognition of the value of Single Molecule, Real-Time (SMRT®) Sequencing technology for structural variant detection and other key genetics applications, as evidenced by the more than 30 presentations to be... Read more